Results 1,101-1,120 of 1,119,504 for in 'Dáil debates' OR in 'Committee meetings' (speaker:Eoin Ó Broin OR speaker:Imelda Munster OR speaker:Réada Cronin OR speaker:Richard Bruton OR speaker:Paul Donnelly OR speaker:Duncan Smith OR speaker:Malcolm Noonan OR speaker:Richard Bruton8 OR speaker:Sorca Clarke OR speaker:Hildegarde Naughton OR speaker:Peter Fitzpatrick OR speaker:Aodhán Ó Ríordáin OR speaker:Patrick O'Donovan OR speaker:Pádraig Mac Lochlainn OR speaker:Rose Conway-Walsh OR speaker:Barry Cowen OR speaker:Steven Matthews OR speaker:Carol Nolan OR speaker:Marian Harkin OR speaker:Martin Kenny OR speaker:Denise Mitchell OR speaker:Alan Farrell OR speaker:Johnny Mythen OR speaker:Neasa Hourigan OR speaker:Robert Troy OR speaker:Donnchadh Ó Laoghaire OR speaker:Catherine Martin OR speaker:Mick Barry OR speaker:Jack Chambers OR speaker:Alan Dillon OR speaker:Heather Humphreys OR speaker:Bernard Durkan OR speaker:Seán Haughey OR speaker:Aindrias Moynihan OR speaker:Willie O'Dea OR speaker:Maurice Quinlivan OR speaker:Niall Collins OR speaker:Cathal Crowe OR speaker:Joe Flaherty OR speaker:Gino Kenny)
- Joint Oireachtas Committee on Jobs, Enterprise and Innovation: General Scheme of the Protection of Employees (Employers’ Insolvency) (Amendment) Bill 2024 (23 Oct 2024)
Maurice Quinlivan: That is fine and I call Deputy Stanton.
- Joint Oireachtas Committee on Jobs, Enterprise and Innovation: General Scheme of the Protection of Employees (Employers’ Insolvency) (Amendment) Bill 2024 (23 Oct 2024)
Maurice Quinlivan: Does anybody else wish to make a contribution? No. That concludes our consideration of this matter today. I thank the witnesses for assisting the committee in the consideration of this important matter. That concludes our business in public session. I propose that we go into private session to consider other business. Is that agreed? Agreed.
- Joint Oireachtas Committee on Health: Issues and Challenges relating to Cardiology: Irish Cardiac Society (23 Oct 2024)
Bernard Durkan: I welcome the witnesses and thank them for giving of their time so readily. How do we compare with the rest of Europe in terms of ability to detect, diagnose and treat? That is my first question. Who is the best in Europe? Who is the worst?
- Joint Oireachtas Committee on Health: Issues and Challenges relating to Cardiology: Irish Cardiac Society (23 Oct 2024)
Bernard Durkan: For instance, whose services should we try to match in order to improve our standards? Who is the best out there, even with the limited information we have available? Who-----
- Joint Oireachtas Committee on Health: Issues and Challenges relating to Cardiology: Irish Cardiac Society (23 Oct 2024)
Bernard Durkan: How are patients identified? For example, can a patient living in Donegal, Kerry or the midlands rest assured that he or she will be detected on time and with sufficient scope for treatment and recovery?
- Joint Oireachtas Committee on Health: Issues and Challenges relating to Cardiology: Irish Cardiac Society (23 Oct 2024)
Bernard Durkan: What is the best way to set about providing the data that would be helpful in dealing with this situation?
- Joint Oireachtas Committee on Health: Issues and Challenges relating to Cardiology: Irish Cardiac Society (23 Oct 2024)
Bernard Durkan: Is that being set up at present? Can it be set up at present? Is it being encouraged? Is the ICS encouraging it or can it do so through the hospital system, GPs and so on?
- Joint Oireachtas Committee on Health: Issues and Challenges relating to Cardiology: Irish Cardiac Society (23 Oct 2024)
Bernard Durkan: Is there a deficit in that area that is identifiable now, and within what timespan is it possible to address the issue?
- Joint Oireachtas Committee on Health: Issues and Challenges relating to Cardiology: Irish Cardiac Society (23 Oct 2024)
Bernard Durkan: We need a strategy somewhat like the national cancer strategy of some years ago.
- Joint Oireachtas Committee on Health: Issues and Challenges relating to Cardiology: Irish Cardiac Society (23 Oct 2024)
Bernard Durkan: As regards women's health, Professor McKeown mentioned that this apparently applies throughout Europe as well in terms of danger of heart attacks, cardiovascular failure, etc. What is being done in Europe now to address that issue, and what is being done here?
- Joint Oireachtas Committee on Health: Issues and Challenges relating to Cardiology: Irish Cardiac Society (23 Oct 2024)
Bernard Durkan: Professor McKeown mentioned a treatment that is restricted at the moment. Why is it restricted? What is it?
- Joint Oireachtas Committee on Health: Issues and Challenges relating to Cardiology: Irish Cardiac Society (23 Oct 2024)
Bernard Durkan: Could we have a comparison done between the older drug and its effectiveness and the new drug, and could we avail of that for the committee, Chairman? I think it would be useful, and it could be used further. Is that possible?
- Joint Oireachtas Committee on Health: Issues and Challenges relating to Cardiology: Irish Cardiac Society (23 Oct 2024)
Bernard Durkan: I have a very short time left. Obviously a strategy is required. Within that strategy certain items, such as the availability of particular drugs that are effective, need to identified. The thing that comes to mind also is there are a number of people who are in danger of heart failure but do not know it for some unknown reason, so the degree to which the services are available for...
- Joint Oireachtas Committee on Health: Issues and Challenges relating to Cardiology: Irish Cardiac Society (23 Oct 2024)
Neasa Hourigan: I will comment on some of the issues around the medicines management programme. For my own clarity, are these injections on cholesterol that we are talking about injections that would be undertaken by a clinician or is it something someone does at home?
- Joint Oireachtas Committee on Health: Issues and Challenges relating to Cardiology: Irish Cardiac Society (23 Oct 2024)
Neasa Hourigan: Okay. That seems to be more prevalent across a number of treatments in healthcare at the moment. Regarding the medicine management programme, I can only imagine there is a huge amount of innovation in this area. If doctors want to move a treatment off the management programme and make it more freely available, how long is that process?
- Joint Oireachtas Committee on Health: Issues and Challenges relating to Cardiology: Irish Cardiac Society (23 Oct 2024)
Neasa Hourigan: My question is on changing the criteria. What is the process and how long does it take?
- Joint Oireachtas Committee on Health: Issues and Challenges relating to Cardiology: Irish Cardiac Society (23 Oct 2024)
Neasa Hourigan: Has the engagement been going on for months or years?
- Joint Oireachtas Committee on Health: Issues and Challenges relating to Cardiology: Irish Cardiac Society (23 Oct 2024)
Neasa Hourigan: That is not great, given that drug innovation happens. We would like there to be a fairly dynamic response from organisations. I want to go back to the registry's issue. This has come up a number of times in other sectors to do with healthcare and anything that is a long-term condition. In a practical sense, what is the hold-up? What is the problem? Is it that there are different...
- Joint Oireachtas Committee on Health: Issues and Challenges relating to Cardiology: Irish Cardiac Society (23 Oct 2024)
Neasa Hourigan: Investment in IT-----
- Joint Oireachtas Committee on Health: Issues and Challenges relating to Cardiology: Irish Cardiac Society (23 Oct 2024)
Neasa Hourigan: There is no structural issue within hospital groups; everyone is perfectly happy to work with that. Is that correct?